D-strand perturbation and amyloid propensity in beta-2 microglobulin

Area of Science:

• Biochemistry
• Structural Biology
• Protein Misfolding Diseases

Background:

• Proteins with beta-sheets require strategies to prevent aggregation and amyloid deposition.
• Human beta-2 microglobulin (β2m) is amyloidogenic, accumulating in severe kidney deficiency and causing pathological deposits.
• The D-strand conformation in β2m has been debated: a β-bulge may protect against aggregation, while a straight strand might promote it.

Purpose of the Study:

• To investigate the role of the β2m D-strand conformation in amyloid aggregation.
• To determine if altering the D-strand structure can inhibit β2m amyloidogenesis.

Main Methods:

• Engineered an Asp53→Pro mutation in β2m to disrupt D-strand regularity.
• Characterized the mutant protein using circular dichroism (CD), X-ray crystallography, and mass spectrometry (MS).
• Assessed the in vitro amyloid aggregation propensity of the engineered β2m mutant.

Main Results:

• The study confirmed the conformational flexibility of the β2m D-strand.
• The Asp53→Pro mutation, designed to perturb D-strand structure, showed only marginal effects.
• Perturbing the D-strand conformation did not significantly protect β2m from amyloid aggregation in vitro.

Conclusions:

• The conformational plasticity of the D-strand is a key feature of β2m.
• Targeting D-strand structure alone may not be sufficient to prevent β2m amyloid aggregation.
• Further research is needed to understand and inhibit β2m amyloidogenesis effectively.